This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2mgs
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_2mgs| PDB=2mgs | SCENE= }} | |
| + | ===Solution structure of CXCL5=== | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/CXCL5_HUMAN CXCL5_HUMAN]] Involved in neutrophil activation. In vitro, ENA-78(8-78) and ENA-78(9-78) show a threefold higher chemotactic activity for neutrophil granulocytes.<ref>PMID:10095777</ref> | ||
| - | + | ==About this Structure== | |
| + | [[2mgs]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MGS OCA]. | ||
| - | + | ==Reference== | |
| + | <references group="xtra"/><references/> | ||
| + | [[Category: Rajarathnam, K.]] | ||
| + | [[Category: Sepuru, K.]] | ||
| + | [[Category: Chemokine]] | ||
| + | [[Category: Cxcr2 activating chemokine]] | ||
| + | [[Category: Dimer]] | ||
| + | [[Category: Ena78]] | ||
| + | [[Category: Neutrophil activating chemokine]] | ||
| + | [[Category: Signaling protein]] | ||
Revision as of 09:27, 2 April 2014
Contents |
Solution structure of CXCL5
Function
[CXCL5_HUMAN] Involved in neutrophil activation. In vitro, ENA-78(8-78) and ENA-78(9-78) show a threefold higher chemotactic activity for neutrophil granulocytes.[1]
About this Structure
2mgs is a 2 chain structure. Full experimental information is available from OCA.
Reference
- ↑ Wuyts A, Govaerts C, Struyf S, Lenaerts JP, Put W, Conings R, Proost P, Van Damme J. Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms. Eur J Biochem. 1999 Mar;260(2):421-9. PMID:10095777
